Advertisement
Screener

GENELUX CORPORATION (GNLX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

GENELUX CORPORATION Cash Flow Breakdown

Cash flow breakdown shows where GENELUX CORPORATION's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $25.27M went out.
  • Fiscal year ended 2025-12-31: from investing, $12.14M came in.
  • Fiscal year ended 2025-12-31: from financing, $9.89M came in.
  • Fiscal year ended 2025-12-31: change in cash, $3.23M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2025-12-31-$25.27M$12.14M$9.55M-$3.23M
2024-12-31-$21.23M-$8.13M$27.69M$813.00K*-$853.00K
2023-12-31-$20.27M-$14.72M-$1.72M$25.14M$20.59M*$9.02M
2022-12-31-$3.57M-$49.00K-$4.10M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$6.44M*$5.97M*$340.00K*
2026-03-31-$6.06M-$8.54M$18.52M$3.94M
2025-12-31-$6.20M*$6.56M*$0.00*
2025-09-30-$6.58M*$4.72M*$0.00*
2025-06-30-$7.06M*-$2.65M*$0.00*
2025-03-31-$5.43M$3.51M$9.55M$7.64M
2024-12-31-$4.30M*$6.67M*$15.00K*
2024-09-30-$5.75M*$3.99M*$0.00*
2024-06-30-$6.82M*-$17.11M*$27.73M*
2024-03-31-$4.35M-$1.69M$688.00K*-$5.36M
2023-12-31-$6.91M*-$13.94M*$0.00*
2023-09-30-$3.36M*-$277.00K*$3.50M*$2.86M*
2023-06-30-$5.42M*-$396.00K*$7.14M*$15.48M*
2023-03-31-$4.59M-$109.00K$14.50M$9.94M
2022-12-31-$1.52M*$0.00*$545.00K*
2022-09-30-$2.47M*-$33.00K*
2022-06-30-$2.41M*-$1.00K*-$564.00K*
2022-03-31$2.83M-$15.00K$2.68M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
Equillium, Inc. (EQ)United States$0.109B-11.27
Quantum Cyber N.V. (QUCY)$0.113B
Immuneering Corp (IMRX)United States$0.113B-12.51
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
ProMIS Neurosciences Inc. (PMN)$0.102B
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95